Učitavanje...
The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study
BACKGROUND: Dopamine agonists (DA) are the first-choice drug for treatment of the early stage of Parkinson’s disease (PD) in subjects younger than 70 years. Recently, a number of third generation DA have been marketed, including transdermal patch of rotigotine and extended release oral formulation o...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3880455/ https://ncbi.nlm.nih.gov/pubmed/24360350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-18-60 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|